The University of Cambridge is planning to build a $125 million biomedical research facility in the United Kingdom. The six-story, 190,000-sf Project Capella will house the Cambridge Stem Cell Institute, the Milner Therapeutics Institute, the Cambridge Institute of Therapeutic Immunology & Infectious Disease, and the Cambridge Centre for Haematopoiesis and Haematological Malignancies. Lean construction methodology will be implemented in the delivery of the facility, which is slated for completion in the second quarter of 2018. The fast-track project team includes architectural firm Fairhursts Design Group, consulting engineer Arup, project manager Arcadis, cost consultant Aecom, and general contractor Kier Group. BREEAM Excellent sustainable design certification will be sought for the facility.
| Organization | Project Role |
|---|---|
|
Arup
|
Consulting Engineer
|
|
AECOM
|
Cost Consultant
|
